925 Shares in Everus (NYSE:ECG) Acquired by HM Payson & Co.

HM Payson & Co. bought a new position in Everus (NYSE:ECG) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 925 shares of the company’s stock, valued at approximately $61,000.

Several other large investors have also recently bought and sold shares of the company. Principal Financial Group Inc. purchased a new stake in shares of Everus in the fourth quarter worth $16,241,000. Yousif Capital Management LLC purchased a new stake in shares of Everus in the 4th quarter valued at about $1,326,000. Principal Securities Inc. purchased a new stake in shares of Everus in the 4th quarter valued at about $27,000. Cascade Investment Advisors Inc. bought a new stake in shares of Everus during the 4th quarter valued at about $1,272,000. Finally, Register Financial Advisors LLC purchased a new position in shares of Everus during the fourth quarter worth about $3,167,000.

Insider Buying and Selling at Everus

In other news, Director Edward A. Ryan purchased 1,400 shares of the business’s stock in a transaction on Tuesday, February 25th. The shares were acquired at an average price of $38.02 per share, with a total value of $53,228.00. Following the acquisition, the director now directly owns 14,928 shares in the company, valued at approximately $567,562.56. The trade was a 10.35 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Rocca Michael Della acquired 1,050 shares of the stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average cost of $47.56 per share, with a total value of $49,938.00. Following the completion of the purchase, the director now owns 2,027 shares of the company’s stock, valued at approximately $96,404.12. The trade was a 107.47 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 3,750 shares of company stock worth $153,853 over the last three months.

Analyst Upgrades and Downgrades

ECG has been the topic of a number of recent analyst reports. Oppenheimer raised their target price on shares of Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, January 7th. Stifel Nicolaus lowered their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Wolfe Research started coverage on shares of Everus in a report on Tuesday, December 3rd. They set a “peer perform” rating for the company.

Everus Stock Up 1.3 %

Shares of ECG opened at $40.05 on Monday. Everus has a 1 year low of $37.18 and a 1 year high of $77.93. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47. The stock has a 50 day moving average price of $60.08.

Everus (NYSE:ECG) last announced its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). On average, equities research analysts forecast that Everus will post 2.49 EPS for the current fiscal year.

Everus Company Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.